Fortrea Holdings Inc (FTRE)

Currency in USD
7.90
0.00(0.00%)
Real-time Data·
FTRE Scorecard
Full Analysis
Operates with a significant debt burden
FTRE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.868.11
52 wk Range
3.9725.28
Key Statistics
Prev. Close
7.9
Open
7.92
Day's Range
7.86-8.11
52 wk Range
3.97-25.28
Volume
517.09K
Average Volume (3m)
2.53M
1-Year Change
-65.95%
Book Value / Share
6.51
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FTRE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.44
Downside
-5.87%
Members' Sentiments
Bearish
Bullish
ProTips
Management has been aggressively buying back shares

Fortrea Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Fortrea Holdings Inc Company Profile

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I – IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. enters into a strategic collaboration with Emery Pharma to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction studies, to certify impurities are below the Acceptable Intake Limit set by U.S. Food and Drug Administration guidelines. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Fortrea Holdings Inc SWOT Analysis


Leadership Shift
Explore Fortrea's strategic pivot as new CEO Anshul Thakral takes the helm, promising fresh perspectives and potential operational enhancements
Financial Resilience
Delve into Fortrea's mixed financial performance, featuring improved margins and a top-line beat, despite bookings challenges and industry headwinds
Market Positioning
Learn how Fortrea, a mid-sized CRO with $2.69B annual revenue, navigates a competitive landscape dominated by larger players amid macroeconomic uncertainties
Future Outlook
Analyst price targets range from $5 to $12, reflecting varied views on Fortrea's growth potential and ability to capitalize on margin improvement initiatives
Read full SWOT analysis

Fortrea Holdings Inc Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of $0.19 beat $0.08 forecast; revenue of $710.3M exceeded expectations, driving 20.27% stock increase
  • Net loss of $374.9M due to goodwill impairment; adjusted net income of $17.6M, up from $2.3M loss last year
  • Full-year 2025 revenue guidance raised to $2.6-$2.7B; adjusted EBITDA guidance reaffirmed at $170-$200M
  • Company transitioning from 'transition phase' to 'transformation phase,' focusing on organic growth and debt repayment
  • Capacity constraints in Clinical Pharmacology Services and competitive pricing environment pose challenges to growth
Last Updated: 06/08/2025, 14:40
Read Full Transcript

Compare FTRE to Peers and Sector

Metrics to compare
FTRE
Peers
Sector
Relationship
P/E Ratio
−0.7x−2.2x−0.5x
PEG Ratio
0.00−0.170.00
Price/Book
1.2x1.2x2.6x
Price / LTM Sales
0.3x1.9x3.3x
Upside (Analyst Target)
−11.4%30.4%40.6%
Fair Value Upside
Unlock23.3%5.3%Unlock

Analyst Ratings

2 Buy
8 Hold
2 Sell
Ratings:
12 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 7.44
(-5.87% Downside)

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
0.19 / 0.08
Revenue / Forecast
710.30M / 631.50M
EPS Revisions
Last 90 days

FTRE Income Statement

People Also Watch

89.53
QRVO
-1.25%
195.03
BDX
+0.01%
3.66
ALIT
0.00%
21.16
KVUE
+0.45%
38.66
MTCH
0.00%

FAQ

What Stock Exchange Does Fortrea Holdings Trade On?

Fortrea Holdings is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Fortrea Holdings?

The stock symbol for Fortrea Holdings is "FTRE."

What Is the Fortrea Holdings Market Cap?

As of today, Fortrea Holdings market cap is 717.32M.

What Is Fortrea Holdings's Earnings Per Share (TTM)?

The Fortrea Holdings EPS (TTM) is -11.44.

From a Technical Analysis Perspective, Is FTRE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Fortrea Holdings Stock Split?

Fortrea Holdings has split 0 times.

How Many Employees Does Fortrea Holdings Have?

Fortrea Holdings has 14500 employees.

What is the current trading status of Fortrea Holdings (FTRE)?

As of 15 Aug 2025, Fortrea Holdings (FTRE) is trading at a price of 7.90, with a previous close of 7.90. The stock has fluctuated within a day range of 7.86 to 8.11, while its 52-week range spans from 3.97 to 25.28.

What Is Fortrea Holdings (FTRE) Price Target According to Analysts?

The average 12-month price target for Fortrea Holdings is USD7.43636, with a high estimate of USD12.8 and a low estimate of USD5. 2 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an -5.87% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.